The microinflammatory state in uremia: Causes and potential consequences

Journal of the American Society of Nephrology

Volumn 12, Issue 7, 2001, Pages 1549-1557

  Kaysen, G A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; CYTOKINE;

ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIALYSIS; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; MORTALITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UREMIA;

EID: 0034918979     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Renal replacement therapy in the United States: Data from the United States Renal Data System
2. Hyperlipidemia of chronic renal failure
3. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities
4. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
5. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
6. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
7. Hyperhomocysteinemia: An independent risk factor for vascular disease
8. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease
9. Role of oxidative stress in cardiovascular diseases
10. The pathogenesis and consequences of AGE formation in uraemia and its treatment
11. Vintage, nutritional status, and survival in hemodialysis patients
12. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
13. Biological variation of acute phase proteins
14. Reference distributions for the negative acute-phase proteins, albumin, transferrin, and transthyretin: A comparison of a large cohort to the world's literature
15. Rapid turnover proteins in critically ill ICU patients: Negative acute phase proteins or nutritional indicators?
16. Study of the molecular mechanisms of decreased liver synthesis of albumin in inflammation
17. Determinants of albumin concentration in hemodialysis patients
18. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function
19. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
20. Relationship between nutritional status and the glomerular filtration rate: Results from the MDRD study
21. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation
22. Protein crosslinking by the Maillard reaction: Dicarbonyl-derived imidazolium crosslinks in aging and diabetes
23. Pathogenesis, prevention, and treatment of diabetic nephropathy
24. Renal catabolism of advanced glycation end products: The fate of pentosidine
25. Plasma advanced glycosylation end-products in maintenance haemodialysis patients
26. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein: A mechanism for the generation of highly reactive alpha-hydroxy and α,β-unsaturated aldehydes by phagocytes at sites of inflammation
27. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells
28. Binding of long-term glycated low density lipoprotein and AGE-albumin by peripheral monocytes and endothelial cells
29. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients
30. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure
31. Alteration in plasma antioxidant capacity in various degrees of chronic renal failure
32. Glutathione antioxidant system as a marker of oxidative stress in chronic renal failure
33. Oxidative stress in haemodialysis
34. Plasma glutathione peroxidase deficiency caused by renal dysfunction
35. Oxidative stress during dialysis: Effect on free radical scavenging enzyme (FRSE) activities and glutathione (GSH) concentration in granulocytes
36. Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure
37. Lipid peroxidation abnormalities in hemodialyzed patients
38. A study of plasmalogen as an index of oxidative stress in patients with chronic renal failure: Evidence of increased oxidative stress in malnourished patients
39. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
40. Serum interleukin-6 in long-term hemodialyzed patients
41. Acute-phase proteins during hemodialysis: Correlations with serum interleukin-1 beta levels and different dialysis membranes
42. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes
43. Cuprophane but not synthetic membrane induces increases in serum tumor necrosis factor-alpha levels during hemodialysis
44. C5b-9 generation and cytokine production in hemodialyzed patients
45. Effect of the dialysis membrane in the treatment of patients with acute renal failure
46. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients
47. Interleukin-6 production of uraemic haemodialysed patients: Effects of different membranes
48. The effects of the dialysis membrane on cytokine release
49. Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers
50. Synthesis of tumor necrosis factor α and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress
51. Dialysate protein losses with bleach processed polysulphone dialyzers
52. Water treatment for hemodialysis
53. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis
54. Sterile and endotoxin free dialysis fluid for hemodialysis
55. Ultrafiltration of dialysis fluid to obtain a sterile solution during hemodialysis
56. Backdiffusion rather than backfiltration enhances endotoxin transport through highly permeable dialysis membranes
57. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients
58. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study
59. Phagocytosis in uremic and hemodialysis patients: A prospective and cross sectional study
60. Septicemia in diabetic hemodialysis patients: Comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients
61. Silent infection in clotted hemodialysis access grafts
62. National surveillance of dialysis associated diseases in the United States, 1995
63. Technique failure in peritoneal dialysis and its impact on patient survival
64. Atherosclerosis, inflammation, and infection
65. Metabolic response to injury and sepsis: Changes in protein metabolism
66. Iron and anemia of chronic disease
67. Acute phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
68. Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron
69. Progress in understanding the pathogenesis of the anemia of chronic disease
70. The Framingham study: Its 50-year legacy and future promise
71. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a)
72. Lipoprotein(a) is a predictor for cardiovascular mortality of hemodialysis patients
73. Effect of acute inflammation on rat apolipoprotein mRNA levels
74. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures
75. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages
76. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: The Hoorn study
77. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The Atherosclerosis Risk in Communities (ARIC) study
78. Inflammatory roles of P-selectin
79. Essential role of P-selectin in the initiation of the inflammatory response induced by hemorrhage and reinfusiom
80. TNF-α, IL-4, and IFN-γ regulate differential expression of P- and E-selectin expression by porcine aortic endothelial cells
81. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response
82. Role of oxidized low density lipoprotein in atherogenesis
83. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein
84. HDL composition and HDL antioxidant capacity in patients on regular haemodialysis